DrugPatentWatch Database Preview
Pennsaid Drug Profile
Which patents cover Pennsaid, and when can generic versions of Pennsaid launch?
Pennsaid is a drug marketed by Hznp and Nuvo Pharms Inc and is included in two NDAs. There are nineteen patents protecting this drug and two Paragraph IV challenges.
This drug has eighteen patent family members in fourteen countries.
The generic ingredient in PENNSAID is diclofenac sodium. There are forty-seven drug master file entries for this compound. Ninety-four suppliers are listed for this compound. Additional details are available on the diclofenac sodium profile page.
Summary for Pennsaid
| International Patents: | 18 |
| US Patents: | 19 |
| Applicants: | 2 |
| NDAs: | 2 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 79 |
| Clinical Trials: | 6 |
| Patent Applications: | 4,842 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for Pennsaid |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for Pennsaid |
| DailyMed Link: | Pennsaid at DailyMed |
Pharmacology for Pennsaid
| Ingredient-type | Nonsteroidal Anti-inflammatory Compounds |
| Drug Class | Nonsteroidal Anti-inflammatory Drug |
| Mechanism of Action | Cyclooxygenase Inhibitors |
| Physiological Effect | Decreased Prostaglandin Production |
US Patents and Regulatory Information for Pennsaid
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hznp | PENNSAID | diclofenac sodium | SOLUTION;TOPICAL | 204623-001 | Jan 16, 2014 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Hznp | PENNSAID | diclofenac sodium | SOLUTION;TOPICAL | 204623-001 | Jan 16, 2014 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Hznp | PENNSAID | diclofenac sodium | SOLUTION;TOPICAL | 204623-001 | Jan 16, 2014 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Hznp | PENNSAID | diclofenac sodium | SOLUTION;TOPICAL | 204623-001 | Jan 16, 2014 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Hznp | PENNSAID | diclofenac sodium | SOLUTION;TOPICAL | 204623-001 | Jan 16, 2014 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Paragraph IV (Patent) Challenges for PENNSAID
| Drugname | Dosage | Strength | RLD | Date |
|---|---|---|---|---|
| ➤ Subscribe | Topical Solution | 2.0% | ➤ Subscribe | ➤ Sign Up |
| ➤ Subscribe | Topical Solution | 1.5% | ➤ Subscribe | ➤ Sign Up |
International Patents for Pennsaid
| Country | Document Number | Estimated Expiration |
|---|---|---|
| China | 101588791 | ➤ Sign Up |
| Japan | 2010506952 | ➤ Sign Up |
| Denmark | 2086504 | ➤ Sign Up |
| Russian Federation | 2009118392 | ➤ Sign Up |
| Canada | 2666398 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
